A federal appeals court heard argument about whether to freeze preventative health screenings and care in the Affordable Care Act (ACA); Canadian wildfires trigger health threats as smoke descends south; a large study displayed the safety of COVID-19 mRNA vaccines in young children.
Appeals Court Deliberating on ACA Freeze
A federal appeals court panel seemed suspicious on Tuesday of calls to execute a nationwide freeze on the Affordable Care Act (ACA) rules for no-cost coverage of preventive care while litigation in the Braidwood v Becerra case continues, reported Politico. Both sides agreed that the individual Texas businesses that sued over the mandate should be protected as litigation proceeds; they were divided on if more harm would be caused by keeping the current coverage rules unbroken for everyone else in the country, or by suspending them nationwide. The Biden administration warned that halting coverage would threaten access to more than 50 types of care for millions of Americans.
Wildfire Smoke Triggers Health Alerts
Officials across nearly half of the United States issued warnings about the health threats from air polluted by smoke from unprecedented early summer wildfires in eastern Canada, according to The New York Times. Wildfire smoke can cause harm even at low concentrations, and those with lung or heart diseases, older adults, children, and pregnant women are at higher risk, said Environment Canada. In New York City, field trips were canceled, and some commuters returned to waring masks if they had to be outdoors.
Large Study Demonstrates COVID-19 Vaccine Safety in Young Children
Messenger RNA vaccines for COVID-19 present little risk to young children, with no myocarditis (inflammation of heart muscle) or pericarditis (inflammation around the heart) seen in vaccine recipients age 0 to 4, reported CIDRAP. Data were collected via the Vaccine Safety Datalink and in collaboration with the CDC that obtained patient information from 8 major US health systems. Children were followed for 9 months. However, vaccine uptake in the age group was low.
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More
Covering antiobesity medications like semaglutide could save Medicare around $500 million annually; preliminary CDC data showed a 3% decline in the number of US overdose deaths last year; the Biden administration recently announced the first national maternal mental health strategy.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Congress Urged to Repeal Comstock Act Threatening Reproductive Rights and Public Health
May 16th 2024In a joint letter addressed to Congress, Healthcare Across Borders, Take Back the Court Action Fund, and UltraViolet Action called out the resurgence of the Comstock Act, urging immediate action to repeal this century-old law that threatens reproductive rights and public health in the US.
Read More
Atypical Marker Expression in T-Cell Acute Lymphoblastic Leukemia/Lymphoma
May 15th 2024Two unique case reports highlight the diagnostic challenges and critical importance of comprehensive immunophenotyping in cases of T-cell acute lymphoblastic leukemia/lymphoma that present without typical immaturity markers but with rare γδ T-cell receptor expression.
Read More